603 related articles for article (PubMed ID: 17369606)
41. [Genotoxicity of carcinogenic substances in humans and animals].
Malaveille C; Bartsch H
J Toxicol Clin Exp; 1989; 9(2 Pt 2):15-25. PubMed ID: 2677321
[TBL] [Abstract][Full Text] [Related]
42. Evaluation of high-throughput genotoxicity assays used in profiling the US EPA ToxCast chemicals.
Knight AW; Little S; Houck K; Dix D; Judson R; Richard A; McCarroll N; Akerman G; Yang C; Birrell L; Walmsley RM
Regul Toxicol Pharmacol; 2009 Nov; 55(2):188-99. PubMed ID: 19591892
[TBL] [Abstract][Full Text] [Related]
43. Strengths and limitations of using repeat-dose toxicity studies to predict effects on fertility.
Dent MP
Regul Toxicol Pharmacol; 2007 Aug; 48(3):241-58. PubMed ID: 17512650
[TBL] [Abstract][Full Text] [Related]
44. Failure of the standard battery of short-term tests in detecting some rodent and human genotoxic carcinogens.
Brambilla G; Martelli A
Toxicology; 2004 Mar; 196(1-2):1-19. PubMed ID: 15036752
[TBL] [Abstract][Full Text] [Related]
45. Evaluating genotoxicity data to identify a mode of action and its application in estimating cancer risk at low doses: A case study involving carbon tetrachloride.
Eastmond DA
Environ Mol Mutagen; 2008 Mar; 49(2):132-41. PubMed ID: 18213651
[TBL] [Abstract][Full Text] [Related]
46. Genetic toxicity assessment: employing the best science for human safety evaluation part III: the comet assay as an alternative to in vitro clastogenicity tests for early drug candidate selection.
Witte I; Plappert U; de Wall H; Hartmann A
Toxicol Sci; 2007 May; 97(1):21-6. PubMed ID: 17204584
[TBL] [Abstract][Full Text] [Related]
47. Current and future application of genetic toxicity assays: the role and value of in vitro mammalian assays.
Elespuru RK; Agarwal R; Atrakchi AH; Bigger CA; Heflich RH; Jagannath DR; Levy DD; Moore MM; Ouyang Y; Robison TW; Sotomayor RE; Cimino MC; Dearfield KL
Toxicol Sci; 2009 Jun; 109(2):172-9. PubMed ID: 19336498
[TBL] [Abstract][Full Text] [Related]
48. Trivalent chromium: assessing the genotoxic risk of an essential trace element and widely used human and animal nutritional supplement.
Eastmond DA; Macgregor JT; Slesinski RS
Crit Rev Toxicol; 2008; 38(3):173-90. PubMed ID: 18324515
[TBL] [Abstract][Full Text] [Related]
49. Application of toxicogenomics to genetic toxicology risk assessment.
Thybaud V; Le Fevre AC; Boitier E
Environ Mol Mutagen; 2007 Jun; 48(5):369-79. PubMed ID: 17567850
[TBL] [Abstract][Full Text] [Related]
50. Review of the in vitro and in vivo genotoxicity of dichlorvos.
Booth ED; Jones E; Elliott BM
Regul Toxicol Pharmacol; 2007 Dec; 49(3):316-26. PubMed ID: 17936460
[TBL] [Abstract][Full Text] [Related]
51. In vitro testing for carcinogens and mutagens.
Santella RM
Occup Med; 1987; 2(1):39-46. PubMed ID: 3306977
[TBL] [Abstract][Full Text] [Related]
52. The use of human cell line reporter gene-based assays in chemical toxicity testing.
Scrivens M; Bhogal N
Toxicol In Vitro; 2007 Oct; 21(7):1233-40. PubMed ID: 17604594
[TBL] [Abstract][Full Text] [Related]
53. Review of the carcinogenic activity of diethanolamine and evidence of choline deficiency as a plausible mode of action.
Leung HW; Kamendulis LM; Stott WT
Regul Toxicol Pharmacol; 2005 Dec; 43(3):260-71. PubMed ID: 16188361
[TBL] [Abstract][Full Text] [Related]
54. Improvements in the reliability of in vitro genotoxicity testing.
Kirkland D
Expert Opin Drug Metab Toxicol; 2011 Dec; 7(12):1513-20. PubMed ID: 22098140
[TBL] [Abstract][Full Text] [Related]
55. Proposed criteria for specific and non-specific chromosomal genotoxicity based on hydrophobic interactions.
Dorn SB; Degen GH; Müller T; Bonacker D; Joosten HF; van der Louw J; van Acker FA; Bolt HM
Mutat Res; 2007 Apr; 628(2):67-75. PubMed ID: 17292661
[TBL] [Abstract][Full Text] [Related]
56. What's new in mutagenicity and carcinogenicity--status of short-term assay systems as tools in genetic toxicology and carcinogenesis.
Pool BL; Schmähl D
Pathol Res Pract; 1987 Oct; 182(5):704-12. PubMed ID: 3317326
[TBL] [Abstract][Full Text] [Related]
57. Propylene oxide: genotoxicity profile of a rodent nasal carcinogen.
Albertini RJ; Sweeney LM
Crit Rev Toxicol; 2007; 37(6):489-520. PubMed ID: 17661214
[TBL] [Abstract][Full Text] [Related]
58. An analysis of results from 305 compounds tested with the yeast RAD54-GFP genotoxicity assay (GreenScreen GC)-including relative predictivity of regulatory tests and rodent carcinogenesis and performance with autofluorescent and coloured compounds.
Knight AW; Billinton N; Cahill PA; Scott A; Harvey JS; Roberts KJ; Tweats DJ; Keenan PO; Walmsley RM
Mutagenesis; 2007 Nov; 22(6):409-16. PubMed ID: 17906314
[TBL] [Abstract][Full Text] [Related]
59. An evaluation of the mode of action framework for mutagenic carcinogens case study: Cyclophosphamide.
McCarroll N; Keshava N; Cimino M; Chu M; Dearfield K; Keshava C; Kligerman A; Owen R; Protzel A; Putzrath R; Schoeny R
Environ Mol Mutagen; 2008 Mar; 49(2):117-31. PubMed ID: 18240158
[TBL] [Abstract][Full Text] [Related]
60. The comet assay as an indicator test for germ cell genotoxicity.
Speit G; Vasquez M; Hartmann A
Mutat Res; 2009; 681(1):3-12. PubMed ID: 18462987
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
